Drug interactions
Dihydroergotamine intranasal + Methylphenidate
Severity: Major
Dihydroergotamine intranasal and Methylphenidate: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Intranasal dihydroergotamine is systemically absorbed and causes vasoconstriction, which may add to the pressor effects of methylphenidate. This raises the risk of hypertension and vasospastic ischemia.
What this interaction means in plain words
Dihydroergotamine intranasal and Methylphenidate can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Additive pharmacodynamic vasoconstriction from ergot receptor agonism and sympathomimetic effects.
What to do
Avoid concurrent use and select an alternative acute migraine treatment. If unavoidable, monitor blood pressure and for limb or cardiac ischemia.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dihydroergotamine intranasal and Methylphenidate, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Methylphenidate
- Isocarboxazid + Methylphenidate Contraindicated
- Linezolid + Methylphenidate Contraindicated
- Methylphenidate + Phenelzine Contraindicated
- Methylphenidate + Procarbazine Contraindicated
- Methylphenidate + Rasagiline Contraindicated
- Methylphenidate + Safinamide Contraindicated
Frequently asked questions
Can I take Dihydroergotamine intranasal with Methylphenidate?
MediHelp rates the interaction as major. Dihydroergotamine intranasal and Methylphenidate can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Intranasal dihydroergotamine is systemically absorbed and causes vasoconstriction, which may add to the pressor effects of methylphenidate. This raises the risk of hypertension and vasospastic ischemia.
How serious is the interaction between Dihydroergotamine intranasal and Methylphenidate?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use and select an alternative acute migraine treatment. If unavoidable, monitor blood pressure and for limb or cardiac ischemia.
What other medicines interact with Methylphenidate?
MediHelp also lists interactions of Methylphenidate with, for example, Isocarboxazid, Linezolid, Phenelzine. The full list is on the Methylphenidate page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
